Telehealth harm-reduction for people at HIV risk
Part of Immune system & allergy, Infections clinical trials.
This study tests whether a telehealth program can reduce harm and lower HIV risk by helping with safer syringe use. It may help if you have recent syringe exchange use and are not currently on HIV prevention pills.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You can speak English or Spanish
- You agree to sign consent and share contact/location info and let them request your medical records
- Your recent rapid HIV test is negative
- You exchanged syringes through an SSP (syringe services program) 2 times in the last 3 months
- You plan to stay in the area for the next 12 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study works with syringe service programs to see if offering opt-out HIV and hepatitis C testing helps more people get screened and connected to care. It focuses on programs that do not already offer this testing and are in high-need areas.
This study tests how well a program combining telemedicine (virtual doctor visits) and peer support can help prevent HIV among people who inject drugs. You'd get trained, attend weekly group sessions, and invite a friend or partner to also take part.
This study tests a couple-focused counseling approach to help male couples reduce drug use and lower the risk of HIV. You and your partner would join sessions together to talk about safer choices and support each other.
This trial tests a digital health program (available with limited in-person contact) to help SGM young people reduce their risk of HIV. You may be a good fit if you’re in the right age range and have had certain types of sex in the last 6 months.
This study looks at how an HIV treatment and prevention program can be improved for people who have HIV plus psychosocial challenges, especially when HIV is not well controlled. You may be able to join if your HIV is recent and higher than target, and you fit one of the specific participant groups.
This study tests a telehealth program to help people who inject drugs in rural Southern areas prevent HIV and get care for hepatitis C. It's designed to be supportive and help you build strength to stay healthy.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.